Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly, acquired 13 shares of common stock through a deferral plan, while also holding 1,449 shares indirectly through a trust.

Summary

• Mary Lynne Hedley, a director at Eli Lilly & Co, has reported a transaction involving the company's common stock.
• On February 20, 2024, Ms. Hedley acquired 13 shares of common stock at a price of $755.66 per share.
• These shares were acquired through the Lilly Directors' Deferral Plan, where they are deferred in lieu of cash compensation and will be settled in shares after her separation from service.
• Ms. Hedley also indirectly owns 1,449 shares of Eli Lilly common stock through a trust.
• She disclaims beneficial ownership of these shares except to the extent of her pecuniary interest.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in the future upon Ms. Hedley's separation from service.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Director share acquisitions through deferral plans are a common practice among large publicly traded companies, such as those in the pharmaceutical sector like Pfizer and Johnson & Johnson.
• These plans are often used to align the interests of directors with those of shareholders by tying a portion of their compensation to the company's long-term performance.
• The specific details of deferral plans can vary, but the general concept of deferring compensation into company stock is widely used.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it demonstrates director confidence in the company.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Common Stock, Beneficial Ownership, SEC Form 4